Email
Password
Remember meForgot password?
    Log in with Twitter

Merck News

Merck & Co. shows how a company can go digital

Pharmaceutical companies are under pressure to reduce expenses while improving results. This is one reason why the sector is looking towards digital technologies. A company down this journey is life science business Merck & Co.

Failure of developmental Alzheimer's drug has wider implications

News that pharmaceutical company Merck has halted a clinical trial for a once promising Alzheimer’s treatment (verubecestat) is not only bad news for the patient group, it could signal that the general view as to the cause of Alzheimer's might be wrong.

Pharma News: Merck and Boehringer report successes

The company Merck announced strong financial results for the first quarter of 2016, based on increases in sales and earnings. Meanwhile, Boehringer Ingelheim has licensed a cancer drug to Horizon Pharma.

Liberia Experiences another Ebola death

Ebola Virus has resurfaced in the West-African regions — leading to calls for stronger steps to counter the persistent nature of this catastrophic epidemic.

Gilead resolves patent dispute over hepatitis drug

After a long-running court battle, pharmaceutical company Gilead must pay another company, Merck & Co, £200 million for breach of patent. The case has been complicated, and both pharma companies lost some ground.

Merck buys Cubist Pharmaceuticals

Major pharmaceutical company Merck has splashed out $8 billion on a smaller company called Cubist Pharmaceuticals. This is related to the search for new antibiotics.

Merck buys Sigma-Aldrich for $17 billion

The German drug maker Merck has acquired the U.S.-based science supply company Sigma-Aldrich in a multi-billion-dollar deal. Merck has been growing its laboratory supply side and it has now become one of the biggest companies in the business.

Drug giant Merck buys hepatitis C biotech treatment company

Cambridge - The drug giant Merck is to acquire Cambridge, Massachusetts-based Idenix Pharmaceuticals. Idenix is focused on developing treatments for hepatitis C.

Exclusive: Bayer, Novartis, others eye Merck's consumer health unit - sources

A handful of consumer and healthcare companies including Bayer AG and Novartis are exploring a deal for Merck & Co Inc's consumer healthcare business, as they se...

Belgium's Ablynx in Merck cancer research tie-up

Brussels - Belgian biotechnology company Ablynx said on Monday it has signed a cancer research cooperation accord with US pharmaceuticals giant Merck & Co. which could be worth up to 1.7 billion euros ($2.3 billion).

United States CDC announces an HPV vaccine recall

The United States Centers for Disease Control and Prevention (CDC) was informed by Merck on Monday that the pharmaceutical company planned to recall one lot of Gardasil [Human Papillomavirus Quadrivalent (types 6, 11, 16, and 18) Vaccine, Recombinant].

Op-Ed: Why are drug companies halting deliveries of cancer drugs?

Big Pharma firms Merck & Biotest have ceased deliveries of a cancer drug to Greek hospitals because of unpaid bills since June 2012.

Op-Ed: Merck Caught Again in Vaccine Fraud

Dr. Maurice Hilleman was, the leading vaccine pioneer in the history of vaccines. He developed more than three dozen vaccines—more than any other scientist in history—and was the developer of Merck's vaccine program.

Merck KGaA announces large job cuts

The drugs and life science company Merck has announced a program of cost savings and job losses in order to boost sales. Unions have reacted angrily to the move and will oppose the planned cuts.

Quebec receives multi-million dollar pharma investment

Montreal - Following a series of site closures and job losses within the pharmaceutical sector in Quebec, the drug giant Merck has announced a major multi-million dollar investment in the region, which involves partnerships with local universities.

Pharmaceutical giant Merck urged to withdraw ‘pig virus’ vaccine

The pharmaceutical giant Merck is being urged to recall a vaccine that is allegedly contaminated with parts of a lethal virus known to infect pigs.

Long Term Fosamax Use May Cause Brittle Bones in Some Women

Mounting evidence is suggesting that using Fosamax, a popular drug prescribed to women suffering from osteoporosis, for more than five years may be causing brittle bones that are more susceptible to fractures in some women

Lawyers Filing Suit - Gardasil Has Suspected Link To Paralysis, Brain Damage & Death

Fed's are probing into records of over 8,000 adverse events reported since the 2006 FDA approval of the Merck vaccine touted as an HPV cancer preventative. Side effects reported include paralysis, immune system disorders and a record of 18 possible deaths

Drug Manufacturer Merck Recalls 1 Million Doses Of Childhood Vaccine

The Hib Vaccine, given to infants beginning at the young of two months, is being recalled due to potential contamination. Testing in a Merck plant in Pennsylvania found a sterilization problem, prompting the massive recall. Parents are told not to worry.

Merck suspends lobbying for vaccine

Merck & Co. is immediately suspending its lobbying campaign to persuade state legislatures to mandate that adolescent girls get the company's new vaccine against cervical cancer as a requirement for school attendance, the company said late Tuesday.

Drug Giant Merck Teams Up With Chinese Herb Company To Seek Cancer Cures

German drug behemouth Merck will team up with China's Chi-Med, a pharmaceutical firm specializing in alternative cancer cures.
 

Search Digital Journal Archives


Set up a news alert for

Merck


Merck Image

Screen dump from the Merck website showing the words  Be well  in their logo.
Screen dump from the Merck website showing the words "Be well" in their logo.
Merck PR
Merck & Co. posted a revenue decline as generic competition and currency fluctuations hurt its resul...
Merck & Co. posted a revenue decline as generic competition and currency fluctuations hurt its results.

Latest News
Top News